A novel composition for STDs and AIDS
The technology suggests a process to formulate high molecular weight compounds in such a dosage form that is hydrophobic in nature, so that these do not swell during production, storage, handling, and administration. But as soon as the formulation is administered into vagina or rectum and comes in contact with vaginal secretions it should swell and form a smooth, homogenous, viscous and bioadhesive gel. At the same time, formulation rapidly disperses, disintegrate and release the active moiety within few minutes of administration. The high molecular weight compounds obviate the drawbacks and possess desired characteristics as detailed above. These compounds are given in a dosage form for reducing the frequency of transmission and prevention of STDs and AIDS.
Sector: Pharmaceuticals
Country: India
Area of Application: Pharma industry.
Keywords: STD, AIDS.
Advantages: Easily amenable to mass production. Not absorbed into systemic circulation. Involves less number of manufacturing steps. Composition is bioadhesive in nature and retains well in vagina. Can be useful for filling both in hard gelatin, soft gelatin and non-gelatin capsules. Neither upset the normal vaginal nor significantly disrupts protective glycolprotein vaginal coating.
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent
Technical specifications:  
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):  
Upload any relevant document:  
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054

Contact Technology Provider